COMBIVENT Trademark

Trademark Overview

On Monday, January 22, 1990, a trademark application was filed for COMBIVENT with the United States Patent and Trademark Office. The USPTO has given the COMBIVENT trademark a serial number of 74020832. The federal status of this trademark filing is REGISTERED AND RENEWED as of Monday, July 11, 2022. This trademark is owned by Boehringer Ingelheim Pharmaceuticals, Inc.. The COMBIVENT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, specifically for treatment of chronic-obstructive pulmonary diseases, comprising albuterol and ipratropium bromide
combivent

General Information

Serial Number74020832
Word MarkCOMBIVENT
Filing DateMonday, January 22, 1990
Status800 - REGISTERED AND RENEWED
Status DateMonday, July 11, 2022
Registration Number1692350
Registration DateTuesday, June 9, 1992
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 14, 1991

Trademark Statements

Goods and Servicespharmaceuticals, specifically for treatment of chronic-obstructive pulmonary diseases, comprising albuterol and ipratropium bromide
Pseudo Markcombination vent

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes018
Class Status Code6 - Active
Class Status DateFriday, March 2, 1990
Primary Code005
First Use Anywhere DateWednesday, February 28, 1990
First Use In Commerce DateWednesday, February 28, 1990

Trademark Owner History

Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877
Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877
Party NameBoehringer Ingelheim Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRidgefield, CT 06877

Trademark Events

Event DateEvent Description
Monday, July 11, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, July 11, 2022REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)
Monday, July 11, 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, July 5, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 31, 2022TEAS SECTION 8 & 9 RECEIVED
Wednesday, June 9, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, May 29, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, May 29, 2012REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Tuesday, May 29, 2012REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, May 10, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, April 26, 2012TEAS SECTION 8 & 9 RECEIVED
Wednesday, January 16, 2008CASE FILE IN TICRS
Monday, January 14, 2008TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 27, 2001REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, December 27, 2001REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, December 10, 2001REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Saturday, November 29, 1997REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 5, 1997REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Tuesday, June 9, 1992REGISTERED-PRINCIPAL REGISTER
Thursday, February 6, 1992ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 5, 1992ASSIGNED TO EXAMINER
Thursday, December 19, 1991STATEMENT OF USE PROCESSING COMPLETE
Monday, November 18, 1991USE AMENDMENT FILED
Tuesday, August 6, 1991NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 1991PUBLISHED FOR OPPOSITION
Friday, April 12, 1991NOTICE OF PUBLICATION
Thursday, January 31, 1991APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 19, 1990CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 17, 1990NON-FINAL ACTION MAILED
Wednesday, April 25, 1990ASSIGNED TO EXAMINER

Related Keywords

combivent comprising albuterol ipratropium bromide diseases pulmonary specifically treatment chronic obstructive